Please assess the completion status of the following clinical trial:

Trial Title: Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 10.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects 65 years or older generally in good health as determined by medical history, physical assessment and clinical judgment of the investigator.~Exclusion Criteria:~* Subjects who have received influenza vaccine within the past 6 month and who have received adjuvanted vaccine in the past two years.~* Subjects with hypersensitivity to vaccine components. Subjects who are on or were recently on immunosuppressive therapy.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): None
- 3 (Type: ACTIVE_COMPARATOR): None
- 4 (Type: ACTIVE_COMPARATOR): None
- 5 (Type: ACTIVE_COMPARATOR): None
- 6 (Type: ACTIVE_COMPARATOR): None
- 7 (Type: ACTIVE_COMPARATOR): None
- 8 (Type: ACTIVE_COMPARATOR): None
- 9 (Type: ACTIVE_COMPARATOR): None
- 10 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).